State Board of Administration of Florida Retirement System’s Lineage Cell Therapeutics LCTX Stock Holding History

State Board of Administration of Florida Retirement System’s Portfolio LCTX Stock Details LCTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-36,970	Closed	-$40.3K	–	2316
2023 Q4	$40.3K	Hold	36,970	–	–	﹤0.01%	2358
2023 Q3	$43.6K	Buy	36,970 +340	+0.9%	+$463	﹤0.01%	2350
2023 Q2	$51.6K	Buy	+36,630	New	+$50.6K	﹤0.01%	2386
2020 Q2	–	Sell	-22,144	Closed	-$18K	–	2337
2020 Q1	$18K	Sell	22,144 -640	-3%	-$637	﹤0.01%	2223
2019 Q4	$20K	Hold	22,784	–	–	﹤0.01%	2271
2019 Q3	$22K	Hold	22,784	–	–	﹤0.01%	2266
2019 Q2	$25K	Hold	22,784	–	–	﹤0.01%	2299
2019 Q1	$30K	Hold	22,784	–	–	﹤0.01%	2314
2018 Q4	$21K	Sell	22,784 -3,258	-13%	-$4.99K	﹤0.01%	2337
2018 Q3	$54K	Hold	26,042	–	–	﹤0.01%	2378
2018 Q2	$47K	Hold	26,042	–	–	﹤0.01%	2390
2018 Q1	$61K	Hold	26,042	–	–	﹤0.01%	2377
2017 Q4	$49K	Hold	26,042	–	–	﹤0.01%	2396
2017 Q3	$65K	Hold	26,042	–	–	﹤0.01%	2403
2017 Q2	$72K	Hold	26,042	–	–	﹤0.01%	2400
2017 Q1	$79K	Hold	26,042	–	–	﹤0.01%	2304
2016 Q4	$82K	Hold	26,042	–	–	﹤0.01%	2337
2016 Q3	$89K	Hold	26,042	–	–	﹤0.01%	2336
2016 Q2	$59K	Hold	26,042	–	–	﹤0.01%	2338
2016 Q1	$65K	Sell	26,042 -2,188	-8%	-$4.88K	﹤0.01%	2365
2015 Q4	$93K	Hold	28,230	–	–	﹤0.01%	2395
2015 Q3	$68K	Hold	28,230	–	–	﹤0.01%	2404
2015 Q2	$83K	Hold	28,230	–	–	﹤0.01%	2414
2015 Q1	$113K	Hold	28,230	–	–	﹤0.01%	2408
2014 Q4	$85K	Hold	28,230	–	–	﹤0.01%	2464
2014 Q3	$72K	Hold	28,230	–	–	﹤0.01%	2479
2014 Q2	$69K	Hold	28,230	–	–	﹤0.01%	2506
2014 Q1	$75K	Hold	28,230	–	–	﹤0.01%	2465
2013 Q4	$82K	Hold	28,230	–	–	﹤0.01%	2480
2013 Q3	$87K	Hold	28,230	–	–	﹤0.01%	2494
2013 Q2	$90K	Buy	+28,230	New	+$90.4K	﹤0.01%	2525

Other funds holding LCTX

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raffles Associates New York $115M AUM 35.69% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PGP

Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

State Board of Administration of Florida Retirement System's LCTX Position: Q1 2024 in Review

State Board of Administration of Florida Retirement System sold out of Lineage Cell Therapeutics (LCTX) in Q1 2024, closing a stake of 36,970 shares — an estimated $40.3K sold.

State Board of Administration of Florida Retirement System first reported a position in LCTX in Q2 2013 and held it in 31 quarters. The position peaked at $113K in Q1 2015. 116 funds tracked by Wall St. Rank hold LCTX as of Q1 2024.

State Board of Administration of Florida Retirement System reported no remaining Lineage Cell Therapeutics position as of Q1 2024 after selling out during the quarter.
State Board of Administration of Florida Retirement System sold 36,970 Lineage Cell Therapeutics shares in Q1 2024, an estimated $40.3K.
State Board of Administration of Florida Retirement System first reported a position in Lineage Cell Therapeutics in Q2 2013 and held it in 31 quarters.
State Board of Administration of Florida Retirement System's Lineage Cell Therapeutics position peaked at $113K in Q1 2015.
116 funds tracked by Wall St. Rank held Lineage Cell Therapeutics as of Q1 2024.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q1 2024, filed 8 May 2024.